Medlive Technology Co., Ltd. (HK:2192) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Medlive Technology Co., Ltd. has announced the renewal of its continuing connected transactions with M3, ensuring compliance with established pricing terms and annual caps. The company has implemented detailed internal controls to monitor and review these transactions, involving multiple departments and regular audits. This move is aimed at maintaining transparency and fairness in their business dealings, assuring shareholders of the company’s commitment to sound financial practices.
For further insights into HK:2192 stock, check out TipRanks’ Stock Analysis page.